Mark Morginstin

620 total citations
10 papers, 23 citations indexed

About

Mark Morginstin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Mark Morginstin has authored 10 papers receiving a total of 23 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Hematology. Recurrent topics in Mark Morginstin's work include Multiple Myeloma Research and Treatments (2 papers), Prostate Cancer Treatment and Research (2 papers) and Cancer Diagnosis and Treatment (2 papers). Mark Morginstin is often cited by papers focused on Multiple Myeloma Research and Treatments (2 papers), Prostate Cancer Treatment and Research (2 papers) and Cancer Diagnosis and Treatment (2 papers). Mark Morginstin collaborates with scholars based in United States and Canada. Mark Morginstin's co-authors include Supakanya Wongrakpanich, Salman Wali, Alan Pollack, Siraj Husain, Gentry Teng King, Paul L. Nguyen, Matthew Chan, Alan C. Hartford, Tyler J. Nelson and Kaveh Zakeri and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Mark Morginstin

6 papers receiving 22 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Morginstin United States 4 11 8 8 6 5 10 23
Annalia Molinari Italy 4 13 1.2× 5 0.6× 9 1.1× 6 1.0× 2 0.4× 7 31
Santiago Bella Argentina 3 13 1.2× 15 1.9× 5 0.6× 3 0.5× 6 1.2× 7 20
Elvira Umyarova United States 3 6 0.5× 3 0.4× 8 1.0× 6 1.0× 3 0.6× 13 17
Anne‐Louise Latif United Kingdom 3 9 0.8× 3 0.4× 20 2.5× 3 0.5× 2 0.4× 6 34
Julie Fu United States 4 11 1.0× 5 0.6× 4 0.5× 21 3.5× 2 0.4× 7 35
Isabel Lentell United Kingdom 3 7 0.6× 4 0.5× 4 0.5× 2 0.3× 9 1.8× 3 21
Adolfo Rosales Argentina 4 14 1.3× 5 0.6× 2 0.3× 5 0.8× 6 1.2× 9 22
Sofia Wong United States 3 6 0.5× 4 0.5× 5 0.6× 5 0.8× 1 0.2× 4 19
M Sopena Spain 3 5 0.5× 3 0.4× 15 1.9× 5 0.8× 2 0.4× 7 23
Carolin Sachs United States 3 12 1.1× 2 0.3× 3 0.4× 6 1.0× 5 1.0× 4 19

Countries citing papers authored by Mark Morginstin

Since Specialization
Citations

This map shows the geographic impact of Mark Morginstin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Morginstin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Morginstin more than expected).

Fields of papers citing papers by Mark Morginstin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Morginstin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Morginstin. The network helps show where Mark Morginstin may publish in the future.

Co-authorship network of co-authors of Mark Morginstin

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Morginstin. A scholar is included among the top collaborators of Mark Morginstin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Morginstin. Mark Morginstin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Chan, Matthew, et al.. (2024). S5123 An Unfortunate Case of Breast Cancer Metastasis to the Stomach. The American Journal of Gastroenterology. 119(10S). S3214–S3215.
3.
Wali, Salman, et al.. (2021). Case Report: Cerebral Venous Sinus Thrombosis and COVID-19 Infection. Frontiers in Medicine. 8. 741594–741594. 3 indexed citations
4.
Nguyen, Paul L., Hsin-Chieh Huang, Elai Davicioni, et al.. (2021). Validation of a 22-gene Genomic Classifier in the NRG Oncology/RTOG 9202, 9413 and 9902 Phase III Randomized Trials: A Biopsy-Based Individual Patient Meta-Analysis in High-Risk Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 111(3). S50–S50. 5 indexed citations
5.
Mell, Loren K., S. Pugh, Tyler J. Nelson, et al.. (2020). Effect Of Hormone Therapy Within Risk Groups Defined By Generalized Competing Event Model: Ancillary Analysis Of NRG Oncology’s RTOG 9408. International Journal of Radiation Oncology*Biology*Physics. 108(3). e863–e864.
6.
Morginstin, Mark, et al.. (2018). Multiple Liver Nodules Mimicking Metastatic Disease as Initial Presentation of Multiple Myeloma. SHILAP Revista de lepidopterología. 2018. 1–6. 7 indexed citations
7.
Jain, Deepanshu, et al.. (2016). Tumor lysis syndrome in metastatic colon cancer after single FOLFOX cycle. International Journal of Case Reports and Images. 7(7). 445–445.
8.
Wongrakpanich, Supakanya, et al.. (2015). Predictors of chemotherapy-induced peripheral neuropathy among breast cancer patients treated with taxanes.. Journal of Clinical Oncology. 33(28_suppl). 90–90. 6 indexed citations
9.
Wongrakpanich, Supakanya, Soumya Patnaik, & Mark Morginstin. (2015). An umbilical nodule in a patient with enlarged uterus. European Journal of Internal Medicine. 27. e3–e4. 1 indexed citations
10.
King, Gentry Teng, Jeong H. Yun, Young Kwang Chae, Matías E. Valsecchi, & Mark Morginstin. (2012). Statin use and the development of bone metastasis in breast cancer patients.. Journal of Clinical Oncology. 30(27_suppl). 40–40. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026